These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30941606)

  • 21. Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease.
    Ellender CM; Law DB; Thomson RM; Eather GW
    Respirology; 2016 Feb; 21(2):357-62. PubMed ID: 26581837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare].
    Casal Román M; Rodríguez López F; Villalba Montoro R; González Requero AI
    Enferm Infecc Microbiol Clin; 1989 Oct; 7(8):432-5. PubMed ID: 2490859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
    Gevaudan MJ; Mallet MN; Bollet C; Gulian C; de Micco P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):585-90. PubMed ID: 2552379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of detailed conditions in DNA probe test by use of Gen-Probe Rapid Diagnostic System for identification of Mycobacterium avium complex and Mycobacterium tuberculosis complex].
    Tomioka H; Sato K; Saito H; Tasaka H; Inoue K
    Kekkaku; 1991 May; 66(5):381-7. PubMed ID: 1908537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment.
    Düzgüneş N; Ashtekar DR; Flasher DL; Ghori N; Debs RJ; Friend DS; Gangadharam PR
    J Infect Dis; 1991 Jul; 164(1):143-51. PubMed ID: 2056201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    FEMS Immunol Med Microbiol; 1999 Jan; 23(1):37-44. PubMed ID: 10030545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
    Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
    Waller EA; Roy A; Brumble L; Khoor A; Johnson MM; Garland JL
    Chest; 2006 Oct; 130(4):1234-41. PubMed ID: 17035461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
    Olivier KN; Griffith DE; Eagle G; McGinnis JP; Micioni L; Liu K; Daley CL; Winthrop KL; Ruoss S; Addrizzo-Harris DJ; Flume PA; Dorgan D; Salathe M; Brown-Elliott BA; Gupta R; Wallace RJ
    Am J Respir Crit Care Med; 2017 Mar; 195(6):814-823. PubMed ID: 27748623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee NY; Lee KS; Woo SY; Shin SJ; Kwon OJ
    Chest; 2012 Dec; 142(6):1482-1488. PubMed ID: 22628488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.
    Renvoisé A; Brossier F; Galati E; Veziris N; Sougakoff W; Aubry A; Robert J; Cambau E; Jarlier V; Bernard C
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7153-5. PubMed ID: 26324275
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.
    Zheng HW; Pang Y; He GX; Song YY; Zhao YL
    Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broncho-Pleural Fistula with Hydropneumothorax at CT: Diagnostic Implications in Mycobacterium avium Complex Lung Disease with Pleural Involvement.
    Yoon HJ; Chung MJ; Lee KS; Kim JS; Park HY; Koh WJ
    Korean J Radiol; 2016; 17(2):295-301. PubMed ID: 26957917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.